Expression of genes for thioredoxin 1 and thioredoxin 2 in multidrug resistance ovarian carcinoma cells SKVLB

The expression of genes for thioredoxin isoforms Trx1 and Trx2 was studied in sensitive SKOV-3 and resistant SKVLB human ovarian carcinoma cells. The development of doxorubicin resistance was accompanied by a significant increase in the expression of TRX1 gene and less pronounced increase in TRX2 gene expression. © Springer Science+Business Media, Inc. 2007.

Authors
Kalinina E.V. 2 , Chernov N.N. 3 , Saprin A.N.1 , Kotova Ya.N.1 , Gavrilova Yu.A.1 , Chermnykh N.S.1 , Shcherbak N.P.1
Publisher
New York Consultants BureauSpringer / Автономная некоммерческая организация Издательство Российской академии медицинских наук
Number of issue
3
Language
English
Pages
301-303
Status
Published
Volume
144
Year
2007
Organizations
  • 1 Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences, Russian Federation
  • 2 Institute of Cytochemistry and Molecular Pharmacology, Moscow, Russian Federation
  • 3 Russian People's Friendship University, Moscow, Russian Federation
Keywords
Doxorubicin; Drug resistance; Thioredoxin
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/3211/
Share

Other records

Volkov S.V., Levov A.N., Soldatenkov A.T., Kolyadina N.M., Volkova O.E., Khrustalev V.N.
Chemistry of Heterocyclic Compounds. Латвийский институт органического синтеза Латвийской академии наук / Springer New York Consultants Bureau. Vol. 43. 2007. P. 1181-1188